| Literature DB >> 36229822 |
Jacob Damgaard Eriksen1,2, Henriette Vind Thaysen3, Katrine Jøssing Emmertsen4, Anders Husted Madsen5, Anders Tøttrup3, Charlotte Buchard Nørager3, Ken Ljungmann3, Niels Thomassen3, Conor Patrick Delaney6, Lene Hjerrild Iversen3,7.
Abstract
BACKGROUND: Despite increasing focus on the technical performance of total mesorectal excision over recent decades, anastomotic leakage (AL) continues to be a serious complication for many patients, even in the hands of experienced surgical teams. This study describes implementation of standardized surgical technique in an effort to reduce variability, decrease the risk of anastomotic leakage, and improve associated short-term outcomes for rectal cancer patients undergoing robot-assisted restorative rectal resection (RRR).Entities:
Keywords: Anastomotic leakage; Implementation; Rectal cancer; Robot; Standardization; Surgery
Mesh:
Substances:
Year: 2022 PMID: 36229822 PMCID: PMC9563459 DOI: 10.1186/s12893-022-01809-3
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.030
Characteristics of patients with rectal cancer undergoing robot-assisted restorative rectal resection at Aarhus University Hospital, 2017–2020
| Period 1: October 2017–August 2018 | Period 2: September 2018–February 2020 | Period 3: March 2020–October 2020 | |
|---|---|---|---|
| N patients | 62 | 74 | 29 |
| Sex | |||
| Males | 47 (75.8) | 43 (58.1) | 22 (75.9) |
| Females | 15 (24.2) | 31 (41.9) | 7 (24.1) |
| Median, age, years (range) | 66 (43–84) | 67 (39–91) | 61 (45–80) |
| Median BMI, kg/m2 (range) | 26 (19–42) | 26 (16–43) | 26 (20–35) |
| American Society of Anesthesiology score (ASA) | |||
| 1 | 14 (22.6) | 22 (29.7) | 11 (37.9) |
| 2 | 39 (62.9) | 45 (60.8) | 16 (55.2) |
| 3 | 9 (14.5) | 7 (9.5) | 1 (3.4) |
| Missing | 0 | 0 | 1 (3.4) |
| Smoking | |||
| Never | 23 (37.1) | 41 (55.4) | 13 (44.8) |
| Previous (≥ 8 weeks) | 25 (40.3) | 17 (23.0) | 10 (34.5) |
| Current | 14 (22.6) | 16 (21.6) | 6 (20.7) |
| Alcohol intake/week (units) | |||
| 0 | 1 (1.6) | 6 (8.1) | 6 (20.7) |
| 1–14 | 56 (90.3) | 65 (87.8) | 21 (72.4) |
| 15–20 | 3 (4.8) | 2 (2.7) | 1 (3.4) |
| ≥ 21 | 2 (3.2) | 1 (1.4) | 1 (3.4) |
| Neoadjuvant (chemo)radio-therapy | |||
| No | 55 (88.7) | 60 (81.1) | 23 (79.3) |
| Yes | 7 (11.3) | 14 (18.9) | 6 (20.7) |
| Tumor height (cm from anal verge) | |||
| 11–15 cm | 34 (54.8) | 41 (55.4) | 13 (44.8) |
| 6–10 cm | 25 (40.3) | 26 (35.1) | 15 (51.7) |
| ≤ 5 cm from anal verge | 3 (4.8) | 0 | 0 |
| Missing | 0 | 7 (9.5) | 1 (3.4) |
| Surgery by certified colorectal surgeon | |||
| No | 6 (9.7) | 3 (4.1) | 1 (3.4) |
| Yes | 56 (90.3) | 71 (95.9) | 28 (96.6) |
| Dexamethasone | |||
| No | 14 (22.6) | 70 (94.6) | 28 (96.6) |
| Yes | 48 (77.4) | 4 (5.4) | 1 (3.4) |
| Surgical Approach | |||
| Robotic | 59 (95.2) | 71 (95.9) | 29 (100) |
| Laparoscopic | 3 (4.8) | 3 (4.1) | 0 |
| Converted from minimally invasive | |||
| No | 60 (96.8) | 73 (98.6) | 28 (96.6) |
| Yes | 2 (3.2) | 1 (1.4) | 1 (3.4) |
| Resection type | |||
| TME | 42 (67.7) | 48 (64.9) | 16 (55.2) |
| PME | 20 (32.3) | 26 (35.1) | 13 (44.8) |
| Missing | |||
| Stapler (type) used for transection of distal rectum | |||
| Robot | 52 (83.9) | 36 (48.6) | 3 (10.3) |
| EndoGIA | 4 (6.5) | 3 (4.1) | 0 |
| Endoscopic, not specified | 1 (1.6) | 0 | 0 |
| Contour | 5 (8.1) | 34 (45.9) | 26 (89.7) |
| TA | 0 | 1 (1.4) | 0 |
| Firings (Endoscopic stapling of distal rectum) | |||
| 1 | 0 | 3 (7.7) | 0 |
| 2 | 47 (82.5) | 30 (76.9) | 3 (100) |
| 3 | 7 (12.3) | 5 (12.8) | 0 |
| 4 | 1 (1.8) | 0 | 0 |
| Missing | 2 (3.5) | 1 (2.6) | 0 |
| Defunctioning stoma for resection type PME | |||
| No | 20 (100) | 26 (100) | 12 (92.3) |
| Yes | 0 | 0 | 1 (7.7) |
| Defunctioning stoma for resection type TME | |||
| No | 0 | 1 (2.1) | 0 |
| Yes | 42 (100) | 47 (97.9) | 16 (100) |
| Mean operation time, min (range) | 228 (100–419) | 262 (160–504) | 281 (185–389) |
| Resections with a written form registered by the surgeon | 58 (93.5) | 63 (85.1) | 25 (86.2) |
| Median length of hospital stay, days (range) | 6 (2–50) | 5 (2–37) | 5 (2–26) |
| Number of patients readmitted | 13 (21.0) | 7 (9.6) | 2 (6.9) |
| Median length of total number of days as readmitted (range) | 5 (1–22) | 8 (2–18) | 6 (3–9) |
Number (percentages), unless indicated otherwise
BMI, body mass index; TME, total mesorectal excision; PME, partial mesorectal excision, TA, thoracoabdominal
Fig. 1Timeline of the study period, October 16th 2017—October 14th 2020 with the standardized changes throughout the period with rectal cancer patients undergoing intended robot-assisted restorative rectal resection at Aarhus University Hospital. TME total mesorectal excision, PME partial mesorectal excision
Patients with rectal cancer undergoing robot-assisted restorative rectal resection with at Aarhus University Hospital, 2017–2020 and the specific steps in the standardization based on the written form registered by the surgeon immediately after the operation or review of medical records. Number (percentages)
| Period 1: October 2017–August 2018 | Period 2: September 2018–February 2020 | Period 3: March 2020–October 2020 | |
|---|---|---|---|
| Central transection of IMA (high ligation) | |||
| No | 23 (37.1) | 10 (13.5) | 1 (3.4) |
| Yes | 34 (54.8) | 55 (74.3) | 25 (86.2) |
| Missing | 5 (8.1) | 9 (12.2) | 3 (10.3) |
| Central transection of IMV | |||
| No | 23 (37.1) | 4 (5.4) | 0 |
| Yes | 35 (56.5) | 66 (89.2) | 28 (96.6) |
| Missing | 4 (6.5) | 4 (5.4) | 1 (3.4) |
| Mobilization of splenic flexure | |||
| No | 20 (32.3) | 5 (6.8) | 0 |
| Yes | 41 (66.1) | 69 (93.2) | 29 (100) |
| Missing | 1 (1.6) | 0 | 0 |
| Transection of the anococcygale ligament (TME) | |||
| No | 0 | 0 | 0 |
| Yes | 40 (95.2) | 41 (85.4) | 15 (93.8) |
| Missing | 2 (4.8) | 7 (14.6) | 1 (6.3) |
| Perpendicular transection of rectum | |||
| No | 0 | 0 | 0 |
| Yes | 56 (90.3) | 61 (82.4) | 26 (89.7) |
| Missing | 6 (9.7) | 13 (17.6) | 3 (10.3) |
| Arterial bleeding of arcade artery | |||
| No | 2 (3.2) | 0 | 0 |
| Yes | 59 (95.2) | 72 (97.3) | 28 (96.6) |
| Missing | 1 (1.6) | 2 (2.7) | 1 (3.4) |
IMA inferior mesenteric artery, IMV inferior mesenteric vein, TME total mesorectal excision
Fig. 2Rectal cancer patients undergoing restorative rectal resection (RRR) with an intended robot-assisted approach at Aarhus University Hospital (AUH), 2017–2020 and with usage of the standardization
The proportion of anastomotic leakage with rectal cancer patients undergoing robot-assisted restorative rectal resection at Aarhus University Hospital, 2017–2020
| Period 1: October 2017–August 2018 | Period 2: September 2018–February 2020 | Period 3: March 2020–October 2020 | |
|---|---|---|---|
| Anastomotic leak | 13/62 21.0% (0.12–0.33) | 9/74 12.2% (0.06–0.22) | 2/29 6.9% (0.01–0.23) |
| Type B (n) | 11 | 8 | 2 |
| Type C (n) | 2 | 1 | 0 |
Number/total and proportion (95% CI), unless indicated otherwise